Vimarsana
Biggest News Aggregation in the World

Stride Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stride Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stride Pharma Today - Breaking & Trending Today

Stocks in news: Stocks in news: Nestle India, Titan, Vodafone Idea, Wipro, Tata Steel - Vimarsana News

Stocks in news: Stocks in news: Nestle India, Titan, Vodafone Idea, Wipro, Tata Steel

The Board of Nestle India approved paying a royalty fee to its parent company Nestle S.A. The payment will be made at a rate of up to 5.25% of total net sales and it is payable in a staggered manner over five years.

Two entities sell Strides Pharma shares worth Rs 81 crore - Vimarsana News

Two entities sell Strides Pharma shares worth Rs 81 crore

Around 11.40 lakh shares were sold, which represent a 1.24 per cent stake in the company. The shares were sold at an average price of Rs 713 per piece, taking the combined transaction value to Rs 81.30 crore.

By 2032, Global Gout Therapeutics Market Size Projected to Reach USD 6.04 Billion, at 8.1% CAGR Growth: Polaris Market Research - Vimarsana News

By 2032, Global Gout Therapeutics Market Size Projected to Reach USD 6.04 Billion, at 8.1% CAGR Growth: Polaris Market Research

/PRNewswire/ -- A latest research report [115+] pages with 360-Degree visibility, titled "Gout Therapeutics Market Share, Size, Trends, Industry Analysis...

Asian Paints, Escorts Kubota, TVS Motor, Stride Pharma: Brokerages see a strong upside in these stocks - Vimarsana News

Asian Paints, Escorts Kubota, TVS Motor, Stride Pharma: Brokerages see a strong upside in these stocks

Asian Paints has formed an elevated base around Rs 2,700 and after consolidating for a prolonged 3-month period has marched forward to break past the consolidation zone.

Non-Opioid Pain Treatment Market to Hit US$ 79.46 Billion By 2031, Due to the Rising Prevalence of Chronic Diseases, says Growth Plus Reports | - Vimarsana News

Non-Opioid Pain Treatment Market to Hit US$ 79.46 Billion By 2031, Due to the Rising Prevalence of Chronic Diseases, says Growth Plus Reports |

According to a recent Growth Plus Reports study, the global non-opioid pain treatment market is estimated to hit US$ 79.46 billion by 2031, with a revenue